World Breast Cancer Therapeutics Markets
World Breast Cancer Therapeutics Markets
RELEASE DATE
18-Aug-2005
18-Aug-2005
REGION
Global
Global
Research Code: B612-01-00-00-00
SKU: HC01106-GL-MR_05168
$3,950.00
In stock
SKU
HC01106-GL-MR_05168
Description
This research service focuses on the market for such therapeutics. It aims to introduce market opportunity for breast cancer therapeutics in the United States, and the top seven markets in Europe (Germany, France, the United Kingdom, Spain, Italy, Benelux and Scandinavia). For the purpose of analysis, a market forecast for the total world breast cancer therapeutics market is carried out and the market is broken down into the above mentioned geographical regions. Key competitors, their market shares and their current and future activities are identified. Finally, market opportunities and success strategies for breast cancer therapeutics in each of the eight regions described above are identified.
Table of Contents
Executive Summary
- Executive Summary
Introduction to Breast Cancer
- Glossary
- Breast Cancer
Therapeutic Targets for Breast Cancer
- Therapeutic Targets
- Genetic Targets
- Hormonal Targets
- Lifestyle Targets
Scope and Assumptions
Breast Cancer Therapeutics
- Research Service Scope
- Research Service Assumptions
Market Challenges
- Overview of Breast Cancer Therapeutics
- Cytotoxic Therapeutics
- Hormonal Therapeutics
- Biologic Therapeutics
Market Drivers and Restraints
- Industry Challenges for the World Breast Cancer Therapeutics Market
World Market Analysis
- Market Drivers for the World Breast Cancer Therapeutics Market
- Market Restraints for the World Breast Cancer Therapeutics Market
United States Market Analysis
- Market Analysis and Forecast
European Market Analysis
- Market Analysis and Forecast
Competitive Analysis
Company Profiles
Strategies for the World Breast Cancer Therapeutics Market
Introduction to Frost & Sullivan Awards
Frost & Sullivan Awards
Healthcare Market Metrics
Cancer Incidence
This research service focuses on the market for such therapeutics. It aims to introduce market opportunity for breast cancer therapeutics in the United States, and the top seven markets in Europe (Germany, France, the United Kingdom, Spain, Italy, Benelux and Scandinavia). For the purpose of analysis, a market forecast for the total world breast cancer therapeutics market is carried out and the market is broken down into the above mentioned geographical regions. Key competitors, their market shares and their current and future activities are identified. Finally, market opportunities and success strategies for breast cancer therapeutics in each of the eight regions described above are identified.
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | B612-01-00-00-00 |
Is Prebook | No |